Baugh & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.67M | Sell |
26,273
-2,463
| -9% | -$574K | 2.95% | 14 |
|
|
2026
Q1 | $7.02M | Sell |
28,736
-347
| -1% | -$80.8K | 3.03% | 13 |
|
|
2025
Q4 | $5.54M | Sell |
29,083
-511
| -2% | -$101K | 2.72% | 16 |
|
|
2025
Q3 | $5.05M | Sell |
29,594
-760
| -3% | -$130K | 2.51% | 16 |
|
|
2025
Q2 | $4.3M | Sell |
30,354
-1,713
| -5% | -$263K | 2.24% | 22 |
|
|
2025
Q1 | $5.05M | Buy |
32,067
+80
| +0.3% | +$12.5K | 2.56% | 19 |
|
|
2024
Q4 | $4.45M | Sell |
31,987
-10
| -0% | -$1.55K | 2.3% | 22 |
|
|
2024
Q3 | $4.94M | Buy |
31,997
+1,014
| +3% | +$162K | 2.54% | 17 |
|
|
2024
Q2 | $4.84M | Buy |
30,983
+7,180
| +30% | +$1.07M | 2.51% | 20 |
|
|
2024
Q1 | $3.77M | Buy |
23,803
+405
| +2% | +$64.5K | 2% | 27 |
|
|
2023
Q4 | $3.67M | Sell |
23,398
-477
| -2% | -$73.1K | 2.11% | 26 |
|
|
2023
Q3 | $3.72M | Sell |
23,875
-49
| -0.2% | -$8.09K | 2.33% | 25 |
|
|
2023
Q2 | $3.96M | Buy |
23,924
+535
| +2% | +$86.3K | 2.38% | 21 |
|
|
2023
Q1 | $3.7M | Sell |
23,389
-487
| -2% | -$78.6K | 2.36% | 20 |
|
|
2022
Q4 | $4.22M | Sell |
23,876
-15
| -0.1% | -$2.59K | 2.73% | 17 |
|
|
2022
Q3 | $3.9M | Sell |
23,891
-34
| -0.1% | -$5.75K | 2.76% | 18 |
|
|
2022
Q2 | $4.25M | Sell |
23,925
-291
| -1% | -$51.8K | 2.86% | 15 |
|
|
2022
Q1 | $4.29M | Sell |
24,216
-80
| -0.3% | -$13.6K | 2.52% | 18 |
|
|
2021
Q4 | $4.16M | Sell |
24,296
-14
| -0.1% | -$2.29K | 2.3% | 19 |
|
|
2021
Q3 | $3.93M | Sell |
24,310
-21
| -0.1% | -$3.58K | 2.4% | 18 |
|
|
2021
Q2 | $4.01M | Sell |
24,331
-150
| -0.6% | -$24.8K | 2.49% | 19 |
|
|
2021
Q1 | $4.02M | Buy |
24,481
+105
| +0.4% | +$17K | 2.66% | 15 |
|
|
2020
Q4 | $3.84M | Sell |
24,376
-525
| -2% | -$77.5K | 2.73% | 16 |
|
|
2020
Q3 | $3.71M | Sell |
24,901
-153
| -0.6% | -$22.6K | 2.91% | 13 |
|
|
2020
Q2 | $3.52M | Sell |
25,054
-10
| -0% | -$1.46K | 2.81% | 15 |
|
|
2020
Q1 | $3.29M | Sell |
25,064
-458
| -2% | -$65K | 3.18% | 12 |
|
|
2019
Q4 | $3.72M | Sell |
25,522
-274
| -1% | -$37.2K | 2.72% | 18 |
|
|
2019
Q3 | $3.34M | Sell |
25,796
-185
| -0.7% | -$24.4K | 2.59% | 22 |
|
|
2019
Q2 | $3.62M | Sell |
25,981
-36
| -0.1% | -$4.98K | 2.87% | 13 |
|
|
2019
Q1 | $3.64M | Sell |
26,017
-180
| -0.7% | -$24.1K | 2.91% | 14 |
|
|
2018
Q4 | $3.38M | Sell |
26,197
-240
| -0.9% | -$33.5K | 2.91% | 13 |
|
|
2018
Q3 | $3.65M | Sell |
26,437
-102
| -0.4% | -$13.6K | 2.92% | 13 |
|
|
2018
Q2 | $3.22M | Sell |
26,539
-986
| -4% | -$123K | 2.81% | 16 |
|
|
2018
Q1 | $3.53M | Buy |
27,525
+1,222
| +5% | +$165K | 2.84% | 15 |
|
|
2017
Q4 | $3.67M | Buy |
+26,303
| New | +$3.66M | 3.1% | 11 |
|
Other funds holding JNJ
AACR
Baugh & Associates's JNJ Position: Q2 2026 in Review
Baugh & Associates reduced its Johnson & Johnson (JNJ) stake by 8.6% in Q2 2026, selling an estimated $574K and leaving 26,273 shares worth $6.67M. The position accounts for 2.95% of the portfolio, ranked #14.
Baugh & Associates first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.02M in Q1 2026. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Baugh & Associates held 26,273 shares of Johnson & Johnson worth $6.67M as of Q2 2026.
- Baugh & Associates sold 2,463 Johnson & Johnson shares in Q2 2026, an estimated $574K.
- Johnson & Johnson made up 2.95% of Baugh & Associates's portfolio in Q2 2026, its #14 holding.
- Baugh & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
- Baugh & Associates's Johnson & Johnson position peaked at $7.02M in Q1 2026.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Baugh & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.